[HTML][HTML] Botulinum toxin intervention in cerebral palsy-induced spasticity management: projected and contradictory effects on skeletal muscles

CSK Keles, F Ates - Toxins, 2022 - ncbi.nlm.nih.gov
Spasticity, following the neurological disorder of cerebral palsy (CP), describes a
pathological condition, the central feature of which is involuntary and prolonged muscle …

Botulinum toxin intervention in cerebral palsy-induced spasticity management: projected and contradictory effects on skeletal muscles

CS Kaya Keles, F Ates - Toxins, 2022 - mdpi.com
Spasticity, following the neurological disorder of cerebral palsy (CP), describes a
pathological condition, the central feature of which is involuntary and prolonged muscle …

[HTML][HTML] Physics-based simulations to predict the differential effects of motor control and musculoskeletal deficits on gait dysfunction in cerebral palsy: a retrospective …

A Falisse, L Pitto, H Kainz, H Hoang… - Frontiers in human …, 2020 - frontiersin.org
Physics-based simulations of walking have the theoretical potential to support clinical
decision-making by predicting the functional outcome of treatments in terms of walking …

Passive muscle properties are altered in children with cerebral palsy before the age of 3 years and are difficult to distinguish clinically from spasticity

M Willerslev‐Olsen, J Lorentzen… - … medicine & Child …, 2013 - Wiley Online Library
Aim Clinical determination of spasticity is confounded by the difficulty in distinguishing reflex
from passive contributions to muscle stiffness. There is, therefore, a risk that children with …

AbobotulinumtoxinA for equinus foot deformity in cerebral palsy: a randomized controlled trial

MR Delgado, A Tilton, B Russman, O Benavides… - …, 2016 - publications.aap.org
BACKGROUND: Although botulinum toxin is a well-established treatment of focal spasticity
in cerebral palsy, most trials have been small, and few have simultaneously assessed …

Prevalence, patterns, and cost of care for children with cerebral palsy enrolled in medicaid managed care

S Pulgar, S Bains, J Gooch, H Chambers… - Journal of managed …, 2019 - jmcp.org
BACKGROUND: In the United States, many children with cerebral palsy (CP) obtain health
care coverage through managed Medicaid, but little is known about the current …

Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength

SA Williams, C Elliott, J Valentine… - Disability and …, 2013 - Taylor & Francis
Purpose: Investigate the combination effects of strength training and Botulinum Toxin Type-A
(BoNT-A) on muscle strength and morphology in children with Cerebral Palsy (CP) …

Effective botulinum neurotoxin injection in treating iliopsoas spasticity

KH Yi, HJ Lee, JH Lee, KL Lee, HJ Kim - Clinical Anatomy, 2021 - Wiley Online Library
Introduction To detect ideal locations for botulinum toxin (BoNT) injection by exploring the
intramuscular nerve arborization of the psoas major and iliacus muscles. Method A modified …

Muscle volume alterations after first botulinum neurotoxin A treatment in children with cerebral palsy: a 6‐month prospective cohort study

C Alexander, C Elliott, J Valentine… - … Medicine & Child …, 2018 - Wiley Online Library
Aim This study aimed to track alterations in muscle volume for 6 months in children with
cerebral palsy (CP) after the first exposure to botulinum neurotoxin A (Bo NT‐A), a …

Botulinum toxin A treatment of the lower extremities in children with cerebral palsy

G Molenaers, K Fagard… - Journal of children's …, 2013 - journals.sagepub.com
Objectives In the last 2 decades, BTX-A is increasingly being used in the management of
spasticity in children with Cerebral Palsy (CP) and there is no doubt about its effect on range …